Ropes & Gray represented Clinical ink and GI Partners in a strategic investment in Clinical ink by Ardan Equity and GI Partners. In the deal, existing investors fully exited their prior investments, and Ardan and GI Partners each invested new equity in a co-control partnership.
Clinical ink is a clinical trial technology company headquartered in Winston-Salem, North Carolina. It provides electronic clinical outcome assessments and connected device solutions to pharmaceutical companies and contract research organizations. The transaction was announced on Oct. 19. Financial terms of the transaction were not disclosed.
GI Partners, founded in 2001, is a private investment firm that has raised more than $50 billion across its private equity, real estate, and data infrastructure strategies.
The Ropes & Gray team included private equity partners Elizabeth Gallucci and Neill Jakobe, employment partner Jen Cormier, tax partner Benjamin Rogers, strategic transactions counsel Christopher Han, private equity associate Lyndsey Greenfield, and executive compensation & benefits associate Madeline Cooper.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.